TYROSINE KINASES IN CANCER RECURRENCE
With
Dr Yu Yu
Program Lead, Curtin Medical Research Institute &
Senior Research Fellow, Curtin Medical School,
Curtin University, Perth, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | July 2025
Dr Yu Yu completed her PhD at Faculty of Medicine, University of Sydney in experimental therapeutics for cancer. She then pursued postdoctoral training at the Richard W. TeLinde Gynecologic Pathology Laboratory, Johns Hopkins University School of Medicine, USA with a focus on understanding the treatment for recurrent ovarian tumour.
Dr Yu Yu leads the Oncology and Gynaecology Research Program at Curtin Medical Research Institute . Dr Yu is also a senior research fellow at Curtin Medical School.
Dr Yu Yu has a strong expertise in developing molecular and cellular therapeutics for cancer. She is a former NHMRC Peter Doherty Fellow and Raine/Robson Fellow. Her studies focused on recurrent cancers, with interests in biomarker and therapeutics development.
Ovarian cancer is one of the deadliest gynaecologic cancers. There are ~300,000 new cases of ovarian cancer worldwide each year. Less than half of women diagnosed survive 5-years after diagnosis. Platinum-based chemotherapy is used to treat ovarian cancers and a variety of other solid cancers. The National Cancer Institute reports 20% of cancer patients worldwide (3.6 million people) receive a platinum-based drug as part of treatment. However, ~20-50% do not respond because of intrinsic resistance. Currently, there is no way to predict response prior to starting platinum chemotherapy.
Dr Yu Yu’s laboratory is working on better ways to treat cancers, particularly ovarian cancers which are resistant to conventional chemotherapy. The aims are for better informed treatment choice and reducing unnecessary exposure to ineffective chemotherapy and its potential adverse effects.
Collaboration partners include St John of God Hospital and King Edward Memorial Hospital, both in Western Australia. Funding for Dr Yu Yu’s research comes from WA Department of Health’s Future Health and Innovation Research Fund, Raine Medical Research Foundation and Endometriosis Foundation of America.
Source: Supplied and adapted
https://orcid.org/0000-0002-0209-0586
-
Next Generation Condom Contraception, Dr Simon Cook
Dr. Simon Cook, Co-Founder and Executive Director of Operations at Eudaemon Technologies, has had a diverse and impactful career journey. Beginning with a background in biotechnology from the University of Wollongong, his focus on bacterial pathogenesis during his PhD led him to study Group A Strep and the streptokinase protein.
Subsequently, Dr. Cook ventured into a unique project funded by the Bill and Melinda Gates Foundation, where he became involved in the development of a next-generation condom to address existing issues such as feel, odour, and taste.
-
New treatments for patients with mental illness
Associate Professor Bernadette Fitzgibbon is a neuroscientist with several decades of experience in researching, developing, and translating novel therapies for mental health and chronic pain conditions. This includes the application and optimisation of brain stimulation and psychedelic therapies, overseeing large multi-site intervention trials, both within Australia and abroad. Through her work, she has developed meaningful collaborations with consumers, volunteers, policy makers, and services providers, ensuring that the outcomes of her work contribute towards real-world clinical impact.
-
Role of Community Paramedicine in Non-Emergency Presentations
Dr Robbie King is a Lecturer in paramedicine and researcher at the Australian Catholic University (ACU) Brisbane. He also continues to provide clinical care as a registered paramedic for community members served by a jurisdictional ambulance service. Dr King has gained significant experience working in an advanced practice, community paramedic style role, holding expert clinical insight into the nuances of paramedic-led community-based healthcare for non-emergency presentations. This often involves adopting a biopsychosocial approach, rather than following the biomedical model more associated with emergency medicine and paramedic culture.
